NCT03254173View on ClinicalTrials.gov

Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 26, 2018

Primary Completion Date

October 17, 2019

Study Completion Date

October 17, 2019

Conditions
Advanced CancerCancer Associated Anorexia - Cachexia
Interventions
DRUG

Mirtazapine 30 mg oral tablets

Mirtazapine 30 mg oral tablets ( Remeron 30 mg oral tablets) , half tablet before sleep for 8 weeks

DRUG

Placebo oral tablets

Placebo oral tablets , half tablet daily before sleep for 8 weeks

Trial Locations (1)

11956

Kasr Al Ainy - Cairo University - Faculty of Medicine, Cairo

All Listed Sponsors
lead

Catherine Naseef Hunter

OTHER

NCT03254173 - Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia | Biotech Hunter | Biotech Hunter